Skip to content
Main home
Home
Publications
Talks
Research
Alzheimer
Members
Windmill
News and views
Main home
Home
Publications
Talks
Research
Alzheimer
Members
Windmill
News and views
PAPERS
POSTERS
RESEARCH
TALKS
ALZHEIMER
SCIENCE
SOCIETY
NEWS AND VIEWS
WINDMILLS OF THE MIND
Members
Link 1
Link 2
Link 3
COMMENT
CONTACT
SEARCH
Index
Information
classic
country
jazz
rock
Memories are made, saved and remembered
Memories make us who we are
You cannot step into
the same river twice - Heraclitus
Where I'm From KALEVALA (1972) People No Names
© 2024 kurkinengroup.com
&
designkurkinen.fi
Kuusamo rapids, Finland
Brain tissue has a remarkable ability to accumulate glutamate. This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons. The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concentrations of glutamate is now well documented. In addition to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission. They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk). Further, the glutamate transporters provide glutamate for synthesis of e.g. GABA, glutathione and protein, and for energy production. They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas and placenta). Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degradation, protein synthesis and targeting, and actual amino acid transport activity and associated ion channel activities. A variety of soluble compounds (e.g. glutamate, cytokines and growth factors) influence glutamate transporter expression and activities. Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurological diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer’s disease, traumatic brain